Skip to main content

Together we are beating cancer

Donate now

Search Results: immunotherapy

Showing 12 out of 570 results
This entry is part 7 of 23 in the series Science Surgery

Our new research partnership is exploring common ground between arthritis and cancer, which could bring benefits to patients on both sides. Our new research partnership is exploring common ground between arthritis and cancer, which could bring benefits to patients on both sides.

by Justine Alford | Analysis | 4 March 2018

4 March 2018

We spoke to Professor Margaret Frame, from the Cancer Research UK Edinburgh Centre, about her OBE for her contribution to cancer research. We spoke to Professor Margaret Frame, from the Cancer Research UK Edinburgh Centre, about her OBE for her contribution to cancer research.

by Gabriella Beer | Analysis | 24 January 2018

24 January 2018

CRISPR genome editing has received lots of attention and hype, so we took a look at what it really means for the future of cancer research. CRISPR genome editing has received lots of attention and hype, so we took a look at what it really means for the future of cancer research.

by Michael Walsh | Analysis | 12 January 2018

12 January 2018

This entry is part 7 of 11 in the series Radiotherapy
  • Health & Medicine
  • Science & Technology

2017 cancer research highlights: a patient's pick

Patients are at the heart of what we do, so we asked a pancreatic cancer survivor to pick the 2017 cancer research highlights that matter to him. Patients are at the heart of what we do, so we asked a pancreatic cancer survivor to pick the 2017 cancer research highlights that matter to him.

by Gabriella Beer | Analysis | 20 December 2017

20 December 2017

artificial intelligence

This week’s news features health warning on cigarettes and long-term results from a trial testing engineered immune cells in aggressive lymphoma. This week’s news features health warning on cigarettes and long-term results from a trial testing engineered immune cells in aggressive lymphoma.

by Katie Roberts | Analysis | 16 December 2017

16 December 2017